相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Safety and efficacy of parenteral iron in children with inflammatory bowel disease
Michael Papadopoulos et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
Marcin Drozd et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study
Sara Valerio de Azevedo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
What are the Considerations in Balancing Benefits and Risks in Iron Treatment? The Benefits of Intravenous Iron
Jay B. Wish
SEMINARS IN DIALYSIS (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
JOURNAL OF CARDIAC FAILURE (2017)
Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron
Jacquelyn M. Powers et al.
JOURNAL OF PEDIATRICS (2017)
Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP)
Christian Breymann et al.
JOURNAL OF PERINATAL MEDICINE (2017)
Ferric Carboxymaltose in Patients With Restless Legs Syndrome and Nonanemic Iron Deficiency: A Randomized Trial
Claudia Trenkwalder et al.
MOVEMENT DISORDERS (2017)
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
Simon D. Roger et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE (FCM) IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
E. Walter et al.
VALUE IN HEALTH (2017)
BUDGET-IMPACT-ANALYSIS OF IRON TREATMENT USING INTRAVENOUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA IN AUSTRIA
E. Walter et al.
VALUE IN HEALTH (2017)
COST SAVINGS OF PERIOPERATIVE ANEMIA TREATMENT WITH FERRIC CARBOXYMALTOSE IN COLORECTAL CANCER SURGERY PATIENTS
K. Levesque et al.
VALUE IN HEALTH (2017)
BUDGET IMPACT OF IV IRON THERAPY WITH FERRIC CARBOXYMALTOSE IN PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY IN FRANCE
S. Bourvignon et al.
VALUE IN HEALTH (2017)
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Ashraf Mikhail et al.
BMC NEPHROLOGY (2017)
Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
Iain C. Macdougall et al.
CLINICAL NEPHROLOGY (2017)
Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
Ulrike Theidel et al.
ESC HEART FAILURE (2017)
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
Dirk J. van Veldhuisen et al.
CIRCULATION (2017)
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Maria Domenica Cappellini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Letter: inconsistency in reporting of hypophosphatemia after intravenous iron
B. Schaefer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice
Antonio Robalo Nunes et al.
ANEMIA (2017)
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
Palle Bager et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
Melvin H. Seid et al.
ANEMIA (2017)
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Jose Luis Calleja et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France
Alain Toledano et al.
SUPPORTIVE CARE IN CANCER (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
Ewa A. Jankowska et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial
Edward Litton et al.
INTENSIVE CARE MEDICINE (2016)
Iron management in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Iain C. Macdougall et al.
KIDNEY INTERNATIONAL (2016)
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
Benedikt Schaefer et al.
PLOS ONE (2016)
Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome
Yong Won Cho et al.
SLEEP MEDICINE (2016)
Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial
Maximo Bernabeu-Wittel et al.
TRANSFUSION (2016)
Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial
Alhossain A. Khalafallah et al.
LANCET HAEMATOLOGY (2016)
Correcting iron deficiency
Jonathan Baird-Gunning et al.
AUSTRALIAN PRESCRIBER (2016)
Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients - A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose
U. Schatz et al.
ATHEROSCLEROSIS SUPPLEMENTS (2015)
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
Axel U. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2015)
Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect
Rebeca Sanchez Gonzalez et al.
MEDICINA CLINICA (2015)
Iron-Deficiency Anemia
Clara Camaschella
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome
Juliane Schneider et al.
SLEEP MEDICINE (2015)
Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency
Gillian M. Keating
DRUGS (2015)
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2015)
Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
S. Hardy et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2015)
Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report
Olus Api et al.
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice
Matthias Bach et al.
ANEMIA (2015)
Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases
Martin W. Laass et al.
BMC GASTROENTEROLOGY (2014)
Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty
E. Bisbe et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
Treatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices A Non-Interventional Study
R. Herfs et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2014)
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial
Jane E. Onken et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Iain C. Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women - PREFER a Randomized, Placebo-Controlled Study
Bernard Favrat et al.
PLOS ONE (2014)
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
T. Steinmetz et al.
ANNALS OF ONCOLOGY (2013)
Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease
Rayko Evstatiev et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
Josep Comin-Colet et al.
EUROPEAN HEART JOURNAL (2013)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
Gerasimos Filippatos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study
Chaim Charytan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life
Ragnar Befrits et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials
Charles F. Barish et al.
ANEMIA (2012)
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery
E. Bisbe et al.
BRITISH JOURNAL OF ANAESTHESIA (2011)
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
Wajeh Y. Qunibi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: A multi-centred, placebo-controlled preliminary clinical trial
Richard P. Allen et al.
SLEEP MEDICINE (2011)
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
David B. Van Wyck et al.
TRANSFUSION (2009)
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease:: The ferric carboxymaltose (FERINJECT®) randomized controlled trial
Stefanie Kulnigg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia
Christian Breymann et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2008)
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia - A randomized controlled trial
David B. Van Wyck et al.
OBSTETRICS AND GYNECOLOGY (2007)
分享论文
